Skip to Main Content

California Health & Wellness uses cookies. By continuing to use our site, you agree to our Privacy Policy and Terms of Use.

California Health & Wellness is no longer a Medi-Cal plan starting January 1, 2024. Regardless of the county you live in, your Medi-Cal service and benefits will not be impacted by the health plan changes since you will be assigned to a new health plan. The county you live in determines your new health plan. Learn more
California Health & Wellness is no longer a Medi-Cal plan starting January 1, 2024. Regardless of the county you live in, your Medi-Cal service and benefits will not be impacted by the health plan changes since you will be assigned to a new health plan. The county you live in determines your new health plan. Learn more

Eliquis Recall

Date: 06/22/17

On June 13, 2017, the U.S. Food and Drug Administration (FDA) announced that Bristol-Myers Squibb Company is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. Bristol-Myers Squibb is taking this precautionary measure based on a customer complaint that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets.

  • Eliquis 5 mg tablets are packaged in 60-count bottles, Lot HN0063, Exp 09/2019, NDC 00003-0894-21
  • This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017.
  • To date, there have not been any reports of injuries or illnesses related to this issue.
  • Bristol-Myers Squibb has notified wholesalers and pharmacies to arrange for return and replacement of any recalled product.

Bristol-Myers Squibb does not encourage that consumers discontinue use of the recalled product. Bristol-Myers Squibb is notifying its distributors and customers including doctors, pharmacies, wholesalers and other customers in the supply chain by letter, fax, email and phone calls. Consumers may return the unused portion of the medication to the pharmacy from which it was obtained. Bristol-Myers Squibb has not yet addressed how it will return and/or reimburse for the recalled products. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

By reviewing claim data from the past 6 months, Envolve Pharmacy Solutions has determined which members processed a prescription for this drug. These members have been sent similar written notification of this recall.

If you have any questions or concerns about Envolve Pharmacy Solutions’ response to the product recall, please contact Iris Ivey, Drug Utilization Review Clinical Pharmacist, at (800) 225-2573, ext. 809-2476 or e-mail at Iris.Ivey@EnvolveHealth.com, or contact Taline Jaghasspanian, Pharm.D., Manager, Clinical Pharmacy Operations, at (818) 676-6959, or email at Taline.Jaghasspanian@centene.com.